echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In 2021, 16 children's medicines will be approved for marketing, and the market for children's medicines will reach 200 billion yuan

    In 2021, 16 children's medicines will be approved for marketing, and the market for children's medicines will reach 200 billion yuan

    • Last Update: 2021-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Since this year, a total of 16 children's drugs have been approved for marketing


    On August 2nd, at the China Children’s Drug Development Forum at the 38th National Medical Industry Information Annual Conference, Yang Yunyun introduced that at present, China’s children have huge data and a wide range of drug needs


    Chai Huiting, deputy director of the Department of Science and Education of the National Health Commission, also mentioned in the China Children’s Drug Development Forum that the growth rate of China’s children’s drug market has always been higher than that of the overall drug market.



    In view of the difficulties in breakthroughs in key technologies of children’s drug research, and the lack of applicable specifications and dosage forms of children’s drugs, the Guidelines for Pharmaceutical Development of Children’s Drugs (Chemicals) (Trial) issued by the Drug Evaluation Center of the State Food and Drug Administration in 2020 are clear and guide The enterprise reasonably researches and develops new preparations that meet the characteristics of children's medicines, supplements the deficiencies of the specifications and dosage forms of children's medicines, further promotes the development of children's medicines in China, meets the needs of children's medicines, and provides research and development ideas and technical guidance for the development of children's medicines


    Chai Huiting believes that appropriate dosage forms and specifications are the most urgent needs for the development of children's medications.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.